Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics

Name: Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics
Start: 2023-05-02T13:00:00-04:00
End: 2023-05-02T14:00:00-04:00

Virtual Event: Regional/Local May 2 1:00 pm to 2:00 pm EDT

Home
Events
Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics

This is a Virtual Event for PsychU members in Illinois, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, South Dakota and Wisconsin.

In this presentation, the objectives are to:

Understand the impact of mood episode recurrence in bipolar I disorder on patient functioning and clinical outcomes
Discuss risk factors for mood episode recurrence, including nonadherence, in patients with bipolar I disorder
Review management strategies, including long-acting injectable antipsychotics (LAIs), to optimize patient outcomes in bipolar I disorder

Featuring

Heather Fields, PharmD, MPH, BCACP (OPDC)

Medical Science Liaison

Pam Wolf, PharmD

Senior Medical Science Liaison

Heather Fields, PharmD, MPH, BCACP and Pam Wolf, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources

Bipolar Disorder By The Numbers

Infographic April 3, 2026

~70% of patients with bipolar disorder may be misdiagnosed, most commonly with depression. Download Infographic
A Look At Adherence In Bipolar Disorder

Infographic March 27, 2026

~60% of individuals are nonadherent—learn about the outcomes, key dimensions, and ways adherence is measured in this downloadable infographic. Download Infographic
ADHD Neurobiology : The Interplay Between Dopamine, Norepinephrine, & Serotonin

Infographic March 25, 2026

An infographic highlighting the ADHD Neurobiology : The Interplay Between Dopamine, Norepinephrine, And Serotonin

Event Navigation

« Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)
Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics »

Join today for instant access to all PsychU content, events, and more!

Membership is free!

"*" indicates required fields

Name*

First Last

Occupational Category*

Specialty*

Adult

Family Medicine

Geriatric

Internal Medicine

Long Term Care

Pediatric

Psychiatry

How did you hear about PsychU?*

Street Address*

Country*

Zip / Postal Code*

City*

State / Province / Region*

Phone Number*

State License Number

NPI Number

State License Number*

NPI Number*

NPI Exception

I certify that I am a Health Care Provider, but I do not have a NPI Number.

Choose Your Unique Login

User Name*

Your username can only contain lowercase letters (a-z) and numbers. Username cannot be the same as email address.

Email*

Enter Email Confirm Email

Password*

Your password must be at least 8 characters Hint: Must use combination of lower case letters, upper case letters, numbers and special characters like !@#$.

Enter Password Confirm Password

I AGREE TO THE FOLLOWING TERMS

I agree to the following terms:*

I certify that I am a physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and/or manager of an organization and that my primary role is to provide, manage, finance, study, or regulate mental health services for adult patients. I understand that any services and information provided on this website are supplied as a professional courtesy and I must continue to form my own conclusions and make my own decisions. I am also aware that Otsuka Pharmaceutical Development & Commercialization, Inc., Otsuka America Pharmaceutical, Inc. and their designees (“Otsuka”) intend to regularly revise this website and reserve the right to decline membership to individuals who Otsuka determines do not meet the aforementioned certification requirements.

I agree to the following terms*

By providing your name, email address, and other information, you are giving Otsuka and companies working with Otsuka permission to send you information from PsychU. Otsuka will not sell or transfer your personal information to any unaffiliated third party, without your prior written consent. Otsuka may monitor your use of the PsychU website to provide you with complimentary information about relevant educational programs based on your use the PsychU website. You agree that, should you use any material provided through PsychU you will attribute the source of that information to “PsychU sponsored by Otsuka Pharmaceutical Development & commercialization, Inc.” For additional information about how Otsuka uses your personal information, how to amend or delete your information, and how to opt out of future communications, please read Otsuka’s Privacy policy, which can be found here. By clicking “Join” and submitting your information, you agree to the terms provided above, and the terms provided in Otsuka’s Terms of Use and Privacy Policy.

This field is hidden when viewing the form

Direct Care Provider

Direct Care Provider Newsletter

False

This field is hidden when viewing the form

Clinician Newsletter

False

This field is hidden when viewing the form

Management Newsletter

False

This field is hidden when viewing the form

user_preferences_account_notifications

False

This field is hidden when viewing the form

user_preferences_webinar_emails

False

Event Registration

Submit any questions you may have regarding the topic of this Event and we will try to answer them during the live presentation:

How Did You Hear About This Event*

Date*

MM slash DD slash YYYY

This field is hidden when viewing the form

otsuka attendence page Event ID

This field is hidden when viewing the form

Event Page Registration Event ID

Meal Opt Out

Attested*

Attested

(Required)

Signature*

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS

PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.

PSYCHU MEMBERSHIP ELIGIBILITY

In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients. NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.

MEMBERSHIP & REGISTRATION

Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.

ATTENDANCE LIMITATIONS

PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.

MEAL REPORTING

The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.

This field is hidden when viewing the form

utm_source

This field is hidden when viewing the form

initial_source

CAPTCHA

Join PsychU Today to receive a wide array of tools and benefits

Join our multidisciplinary community that is improving mental health care… together
Quickly learn more about the topics you're interested in
Access an award-winning library of on-demand mental health resources
Gain key insights from industry expert & thought leaders

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Thank You For Attending Today’s Webinar

About This Event

Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics

Featuring

Heather Fields, PharmD, MPH, BCACP (OPDC)

Pam Wolf, PharmD

Registration

Related Resources

Bipolar Disorder By The Numbers

A Look At Adherence In Bipolar Disorder

ADHD Neurobiology : The Interplay Between Dopamine, Norepinephrine, & Serotonin

Event Navigation

Join today for instant access to all PsychU content, events, and more!

Membership is free!

Choose Your Unique Login

I AGREE TO THE FOLLOWING TERMS

Event Registration

Join PsychU Today to receive a wide array of tools and benefits

Stay Connected: